Drug Shortage Report for AVAPRO

Last updated on 2019-11-29 History
Report ID 100061
Drug Identification Number 02237925
Brand name AVAPRO
Common or Proper name Avapro
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) IRBESARTAN
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-01-03
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2019-11-29
Company comments Demand increase and supply delay - The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-11-29 French Compare
v3 2019-11-29 English Compare
v2 2019-11-29 French Compare
v1 2019-11-29 English Compare